Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Paolo Vigneri, MD, PhD, Fabio Stagno, MD, Stefania Stella, PhD, Alessandra Cupri, MD, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Vincenzo Abbadessa, MD, Maura Brugiatelli, MD, Patrizia Guglielmo, MD, Caterina Musolino, MD, Diamante Turri, MD, Mario Russo, MD, Guido Pagnucco, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, Angelo Messina, MD, Francesco Di Raimondo, MD

Blood (2010) 116 (21): 3426.

https://doi.org/10.1182/blood.V116.21.3426.3426

Published: 2010

Journal Articles

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

Esther Natalie Oliva, MD, Valeria Santini, MD, Poloni Antonella, MD, Vincenzo Liso, MD, Daniela Cilloni, MD, Adelmo Terenzi, MD, Patrizia Guglielmo, MD, Riccardo Ghio, MD, Agostino Cortelezzi, MD, Giampietro Semenzato, MD, Cristina Clissa, MD, Flavia Salvi, MD, Oreste Villani, MD, Maria Antonietta Aloe Spiriti, MD

Blood (2009) 114 (22): 3822.

https://doi.org/10.1182/blood.V114.22.3822.3822

Published: 2009

Journal Articles

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

Blood (2009) 114 (22): 4276.

https://doi.org/10.1182/blood.V114.22.4276.4276

Published: 2009

Journal Articles

Quality of Life Scores Have a Prognostic Significance In Elderly AML Patients.

Esther Natalie Oliva, MD, Roberto Latagliata, Giorgina Specchia, Francesca Ronco, Giuliana Alimena, Domenico Pastore, Stella Impera, Patrizia Guglielmo, Ida Carmosino, Iolanda Vincelli, Caterina Alati, Massimo Breccia, Laura Napoleone, Francesco Nobile

Blood (2008) 112 (11): 1949.

https://doi.org/10.1182/blood.V112.11.1949.1949

Published: 2008

Journal Articles

BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B

Alessandra Aloisi, Sandra Di Gregorio, Fabio Stagno, Patrizia Guglielmo, Francesca Mannino, Maria Pia Sormani, Paolo Bruzzi, Carlo Gambacorti-Passerini, Giuseppe Saglio, Salvatore Venuta, Rosario Giustolisi, Angelo Messina, Paolo Vigneri

Blood (2006) 107 (4): 1591–1598.

https://doi.org/10.1182/blood-2005-05-2123

Published: 2006

Includes: Supplemental data

Journal Articles

Flow Cytometric Detection and Phenotype of Circulating CD34+ Cells in Patients Affected by Chronic Lymphocytic Leukemia.

Fabio Stagno, MD, PhD, Nunziata Laura Parrinello, BD, Giovannella Fargione, BD, Anna Triolo, BD, Antonella Privitera, BD, Elisa Seria, BD, Francesca Mannino, MD, Francesco Di Raimondo, MD, Patrizia Guglielmo, MD, Rosario Giustolisi, MD

Blood (2005) 106 (11): 4329.

https://doi.org/10.1182/blood.V106.11.4329.4329

Published: 2005

Journal Articles

Successful Healing of Hydroxyurea-Related Leg Ulcers With Topical Granulocyte-Macrophage Colony-Stimulating Factor

Fabio Stagno, Patrizia Guglielmo, Ugo Consoli, Paolo Fiumara, Mario Russo, Rosario Giustolisi

Blood (1999) 94 (4): 1479–1480.

https://doi.org/10.1182/blood.V94.4.1479

Published: 1999

NARROW

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

Quality of Life Scores Have a Prognostic Significance In Elderly AML Patients.

BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B

Flow Cytometric Detection and Phenotype of Circulating CD34+ Cells in Patients Affected by Chronic Lymphocytic Leukemia.

Successful Healing of Hydroxyurea-Related Leg Ulcers With Topical Granulocyte-Macrophage Colony-Stimulating Factor

Email alerts

ASH Publications

American Society of Hematology

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

Quality of Life Scores Have a Prognostic Significance In Elderly AML Patients.

BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B

Flow Cytometric Detection and Phenotype of Circulating CD34+ Cells in Patients Affected by Chronic Lymphocytic Leukemia.

Successful Healing of Hydroxyurea-Related Leg Ulcers With Topical Granulocyte-Macrophage Colony-Stimulating Factor

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only